High-Dose IV Administration of Rasburicase Suppresses Anti-rasburicase Antibodies, Depletes Rasburicase-Specific Lymphocytes, and Upregulates Treg Cells
Crossref DOI link: https://doi.org/10.1208/s12248-020-00461-0
Published Online: 2020-05-27
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Hui
Feldman, Gerald M. http://orcid.org/0000-0001-7805-8702
Max, Edward E.
Text and Data Mining valid from 2020-05-27
Version of Record valid from 2020-05-27
Article History
Received: 15 November 2019
Accepted: 28 April 2020
First Online: 27 May 2020
Compliance with Ethical Standards
:
: The authors declare that they have no competing interests.